These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2630302)

  • 1. Direct measurement of muscarinic agents in the central nervous system of mice using ex vivo binding.
    Freedman SB; Harley EA; Patel S
    Eur J Pharmacol; 1989 Dec; 174(2-3):253-60. PubMed ID: 2630302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo characterisation of novel efficacious muscarinic receptor agonists.
    Freedman SB; Harley EA; Marwood RS; Patel S
    Eur J Pharmacol; 1990 Oct; 187(2):193-9. PubMed ID: 2272360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
    Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
    Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and peripheral mediation of hypothermia, tremor and salivation induced by muscarinic agonists in mice.
    Sánchez C; Meier E
    Pharmacol Toxicol; 1993; 72(4-5):262-7. PubMed ID: 8372044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
    Ringdahl B; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
    Ringdahl B; Katz ED; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):210-5. PubMed ID: 2709331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954.
    Wanibuchi F; Konishi T; Harada M; Terai M; Hidaka K; Tamura T; Tsukamoto S; Usuda S
    Eur J Pharmacol; 1990 Oct; 187(3):479-86. PubMed ID: 1963596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.
    Bymaster FP; Carter PA; Peters SC; Zhang W; Ward JS; Mitch CH; Calligaro DO; Whitesitt CA; DeLapp N; Shannon HE; Rimvall K; Jeppesen L; Sheardown MJ; Fink-Jensen A; Sauerberg P
    Brain Res; 1998 Jun; 795(1-2):179-90. PubMed ID: 9622623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermic response of selective muscarinic agonists and antagonists in rat.
    Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1991 Feb; 29(2):131-5. PubMed ID: 1869296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothermia induced by cholinomimetic drugs is blocked by galanin: possible involvement of ATP-sensitive K+ channels.
    Patel S; Hutson PH
    Eur J Pharmacol; 1994 Apr; 255(1-3):25-32. PubMed ID: 7517882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J; Lembøl HL; Meier E; Pedersen H
    Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies.
    Engström C; Undén A; Ladinsky H; Consolo S; Bartfai T
    Psychopharmacology (Berl); 1987; 91(2):161-7. PubMed ID: 3107028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes.
    Messer WS; Ellerbrock B; Price M; Hoss W
    Biochem Pharmacol; 1989 Mar; 38(5):837-50. PubMed ID: 2564779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
    Aronstam RS; Ryan US; Catravas JD
    Pharmacology; 1992; 44(6):324-33. PubMed ID: 1508962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus properties of muscarinic agonists.
    Jung M; Costa L; Shearman GT; Kelly PH
    Psychopharmacology (Berl); 1987; 93(2):139-45. PubMed ID: 3122245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic scopolamine treatment and brain cholinergic function.
    Marks MJ; O'Connor MF; Artman LD; Burch JB; Collins AC
    Pharmacol Biochem Behav; 1984 May; 20(5):771-7. PubMed ID: 6739517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat.
    Ray CA; Blin J; Chase TN; Piercey MF
    Neuropharmacology; 1992 Nov; 31(11):1193-9. PubMed ID: 1475026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modulation of the number of muscarinic receptors in rat brain by cholinergic ligands.
    Ben-Barak J; Gazit H; Silman I; Dudai Y
    Eur J Pharmacol; 1981 Aug; 74(1):73-81. PubMed ID: 7318895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.